• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Amrinone, forerunner of novel cardiotonic agents, caused paradigm shift of heart failure pharmacotherapy.

作者信息

Endoh Masao

机构信息

Department of Pharmacology, Yamagata University School of Medicine, Yamagata, Japan.

出版信息

Circ Res. 2013 Aug 2;113(4):358-61. doi: 10.1161/CIRCRESAHA.113.301689.

DOI:10.1161/CIRCRESAHA.113.301689
PMID:23908328
Abstract
摘要

相似文献

1
Amrinone, forerunner of novel cardiotonic agents, caused paradigm shift of heart failure pharmacotherapy.氨力农作为新型强心剂的先驱，引发了心力衰竭药物治疗的范式转变。
Circ Res. 2013 Aug 2;113(4):358-61. doi: 10.1161/CIRCRESAHA.113.301689.
2
[New inotropic agents in the treatment of refractory congestive heart failure].[治疗难治性充血性心力衰竭的新型正性肌力药物]
Harefuah. 1988 Mar 15;114(6):290-3.
3
[A preliminary study on the effect of oral amrinone in refractory congestive heart failure].口服氨力农治疗难治性充血性心力衰竭疗效的初步研究
Zhonghua Xin Xue Guan Bing Za Zhi. 1986 Jun;14(3):142-4, 191.
4
The improvement of cardiac performance by amrinone, a new cardiotonic drug, in an experimental failing heart preparation of the dog.新型强心药氨力农对犬实验性衰竭心脏模型心脏功能的改善作用。
Jpn Heart J. 1982 Nov;23(6):975-80. doi: 10.1536/ihj.23.975.
5
[Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].一种新型正性肌力药物对心肺制备模型心力衰竭的影响
Arch Inst Cardiol Mex. 1979 Sep-Oct;49(5):892-907.
6
[Amrinone, a new cardiotonic agent].[氨力农，一种新型强心剂]
Nihon Rinsho. 1983 Dec;41(12):2691-7.
7
[New inotropic drugs].[新型正性肌力药物]
G Ital Cardiol. 1982;12(2):139-46.
8
[The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].[氨力农和依诺昔酮在重症心力衰竭患者中的血流动力学特征]
Z Kardiol. 1991;80 Suppl 4:63-7.
9
[The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].[多巴酚丁胺 - 多巴胺联合用药与氨力农治疗伴有明显水肿体征并并发功能性肾衰竭的充血性心力衰竭。两种不同的变力性刺激和利尿增强模型的比较]
Minerva Cardioangiol. 1998 May;46(5):163-74.
10
Newer cardiotonic agents: implications for patients with heart failure and ischemic heart disease.新型强心剂：对心力衰竭和缺血性心脏病患者的影响。
J Cardiothorac Anesth. 1987 Feb;1(1):59-70. doi: 10.1016/s0888-6296(87)92838-9.

引用本文的文献

1
Targeting Troponin C with Small Molecules Containing Diphenyl Moieties: Calcium Sensitivity Effects on Striated Muscles and Structure-Activity Relationship.靶向含有二苯基部分的小分子肌钙蛋白 C：横纹肌的钙敏感性影响及构效关系。
J Chem Inf Model. 2023 Jun 12;63(11):3462-3473. doi: 10.1021/acs.jcim.3c00196. Epub 2023 May 19.
2
Targeting Troponin C with Small Molecules Containing Diphenyl Moieties: Calcium Sensitivity Effects on Striated Muscle and Structure Activity Relationship.用含二苯基部分的小分子靶向肌钙蛋白C：对横纹肌的钙敏感性影响及构效关系
bioRxiv. 2023 Feb 6:2023.02.06.527323. doi: 10.1101/2023.02.06.527323.
3
Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia-Effects on Cellular Elimination of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate.
在中度和重度低温状态下使用磷酸二酯酶3抑制剂治疗心血管功能障碍——对细胞内环磷酸腺苷和环磷酸鸟苷清除的影响
Front Physiol. 2022 Jul 13;13:923091. doi: 10.3389/fphys.2022.923091. eCollection 2022.
4
Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.为什么正性肌力药物在慢性心力衰竭中失败了？来自既往正性肌力药物试验的教训。
Eur J Heart Fail. 2019 Sep;21(9):1064-1078. doi: 10.1002/ejhf.1557. Epub 2019 Aug 13.
5
The calcium sensitizer drug MCI-154 binds the structural C-terminal domain of cardiac troponin C.钙敏化剂药物MCI - 154与心肌肌钙蛋白C的结构C末端结构域结合。
Biochem Biophys Rep. 2018 Nov 1;16:145-151. doi: 10.1016/j.bbrep.2018.10.012. eCollection 2018 Dec.
6
Targeting the sarcomere to correct muscle function.靶向肌节以纠正肌肉功能。
Nat Rev Drug Discov. 2015 May;14(5):313-28. doi: 10.1038/nrd4554. Epub 2015 Apr 17.
7
Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure.匹莫苯丹对遗传性扩张型心肌病和进行性心力衰竭小鼠的阶段依赖性益处和风险
Br J Pharmacol. 2015 May;172(9):2369-82. doi: 10.1111/bph.13062. Epub 2015 Mar 17.